• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    23.90
  • 漲跌
    ▼0.05
  • 漲幅
    -0.21%
  • 成交量
    335張
  • 產業
    上櫃 生技醫療類股

  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
健亞 (4130)籌碼相關－元大-金華 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

元大-金華 券商分點個股進出

元大-金華 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/20824.65424.5523.7042831.41%
2025/01/16124.30524.9425.30-4225-1.77%
2025/01/15425.2000.0024.8541872.14%
2025/01/0600.00121.0020.90-184-1.19%
2025/01/0300.00120.9520.70-186-1.16%
2025/01/0200.00120.9020.70-186-1.16%
2024/12/3100.00021.0020.80086-0.02%
2024/12/03021.905.122.0021.95-5.197-5.22%
2024/11/28121.75121.9521.7001000.00%
2024/11/22121.90122.1021.8001010.00%
2024/11/20121.70121.8521.9501020.00%
2024/11/1900.000.421.8521.95-0.4104-0.37%
2024/10/1700.000.122.3022.30-0.1158-0.04%
2024/10/0800.00123.0022.75-1169-0.59%
2024/10/0700.001.623.1223.10-1.6176-0.92%
2024/10/0400.00322.9823.20-3178-1.68%
2024/09/2600.00322.8022.75-3180-1.66%
2024/09/2500.00422.7622.75-4181-2.20%
2024/09/1300.00023.9521.8501980.00%
2024/09/1000.00521.8021.60-5204-2.45%
2024/09/05122.00122.3022.0002050.00%
2024/09/0200.00122.7022.10-1208-0.48%
2024/08/2900.00122.6522.60-1208-0.48%
2024/08/2800.00222.5322.55-2210-0.95%
2024/08/21022.5000.0022.4002200.00%
2024/08/19022.9000.0022.9502160.01%
2024/08/0700.00222.0022.35-2226-0.88%
2024/08/0500.00321.6521.65-3221-1.35%
2024/08/0200.00222.9022.90-2213-0.94%
2024/07/29123.0500.0023.0012160.46%
2024/07/23123.6000.0023.6512130.47%
2024/07/221023.4000.0023.40102144.66%
2024/07/15024.1000.0024.2002060.00%
2024/07/11424.1300.0024.0542051.95%
2024/07/1000.00224.3024.30-2207-0.97%
2024/07/0900.00224.2024.05-2208-0.96%
2024/06/24524.7000.0024.5551922.60%
2024/06/1400.00124.5524.65-1188-0.53%
2024/06/12124.3000.0024.3011890.53%
2024/06/1100.00124.4524.55-1189-0.53%
2024/06/07124.10124.3524.2501890.00%
2024/06/06124.2000.0024.2511910.52%
2024/06/05224.05224.2524.3501930.00%
2024/06/0300.00124.3024.25-1200-0.50%
2024/05/29224.03224.1524.1002010.00%
2024/05/28124.10124.2524.2502050.00%
2024/05/27124.00124.2023.9502040.00%
2024/05/2400.00123.9524.00-1201-0.50%
2024/05/22124.05124.1524.1002060.00%
2024/05/21124.35124.6024.1502190.00%
2024/05/10223.70223.7823.8502290.00%
2024/05/03324.2500.0024.0532201.36%
2024/04/2900.00224.4024.35-2214-0.93%
2024/04/23424.1900.0024.2542181.83%
2024/04/22123.8000.0023.9012170.46%
2024/04/18124.30124.3524.3002150.00%
2024/04/17424.23424.5024.1502150.00%
2024/04/11825.0800.0025.0582133.74%
2024/03/28025.2000.0025.0502240.00%
2024/03/27025.2800.0025.0002240.00%
2024/03/18025.4000.0025.0002320.00%
2024/03/15025.4000.0025.1002330.00%
2024/03/1100.00124.9525.10-1237-0.42%
2024/03/08125.10125.0525.0502410.00%
2024/03/07125.75126.0025.7002440.00%
2024/03/0600.00225.8025.75-2247-0.81%
2024/03/05225.80225.7525.7502460.00%
2024/03/04226.0000.0026.0022510.79%
2024/02/23125.7500.0025.6012730.37%
2024/02/2200.00125.9526.10-1271-0.37%
2024/02/21125.70125.9025.6002590.00%
2024/02/1600.00125.4525.60-1257-0.39%
2024/02/1500.00125.3525.35-1257-0.39%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨－2022/09/12
...詳全文
健亞轉投資浩宇超音波D針具追蹤系統 獲美台上市許可UDN聯合新聞網－2022/05/09
健亞（4130）今（9）日宣布，轉投資浩宇生醫公司開發的NAVIRFA（納維爾）超音波3D手術針具追蹤系統，雙雙取得美、......詳全文
健亞轉拓資浩宇NaviFUS®產品 首獲研究用途設備訂單UDN聯合新聞網－2021/03/15
健亞（4130）今（15）日宣布，轉投資的浩宇生醫，下半年將取得肝癌治療產品NAVIRFA®之美國510（k）及台灣二類......詳全文
健亞 相關文章